Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 3, 2021
November 5, 2024
b4c70c8e-e987-4e21-bc26-899f532ad5a1
Related Documents
Pre-Launch Activities Importation Requests (PLAIR): Guidance for Industry
Guidance DocumentMarch 1, 2022Center for Drug Evaluation and Research
Special Protocol Assessment Guidance for Industry
Guidance DocumentApril 16, 2018Center for Drug Evaluation and Research
Tropical Disease Priority Review Vouchers
Guidance DocumentOctober 6, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox